# Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection

> **NCT04727788** · — · ACTIVE_NOT_RECRUITING · sponsor: **Verici Dx** · enrollment: 550 (estimated)

## Conditions studied

- Kidney Transplant Rejection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04727788
- **Lead sponsor:** Verici Dx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-03-21
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04727788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04727788, "Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04727788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*